Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
Clinical trial NCT07160790 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07160790
- Sponsor
- Onconic Therapeutics Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-02
- Primary completion
- 2026-06-30
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.